[{"Assets_0_Q1_USD":2172232000.0,"CommonStockSharesOutstanding_0_Q1_shares":777413184.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-171975000.0,"NetIncomeLoss_1_Q1_USD":-167640000.0,"StockholdersEquity_0_Q1_USD":1608769000.0,"Ticker":"BGNE","CIK":"1651308","name":"BEIGENE, LTD.","OfficialName":"BeiGene Ltd. American Depositary Shares","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"18163188203.0","Country":"Cayman Islands","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190509"}]